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Abstract: Somatostatin (SRIF) is a putative peptide neu- 
rotransmitter that may interact with brain capillaries fol- 
lowing neurosecretion of the peptide. The present studies 
investigate the binding and metabolism of SRIF ana- 
logues in isolated bovine brain microvessels. '"1- 
[TyrlISRIF was rapidly degraded by capillary aminopep- 
tidase with a half-time of approximately 3 min at 23°C. 
The microvessel aminopeptidase had a low affinity and 
high capacity for the peptide, K ,  = 76 JLM and V,,, = 
74 nmol min-I mg,- I. 12SI-[Tyr"]SRIF was converted to 
free iodotyrosine at a much slower rate, presumably by 
a lower-activity endopeptidase. '*'I-[Tyr "ISRIF was rap- 
idly bound by microvessels, whereas another basic pep- 
tide, [Tyr8]bradykinin, or an acidic peptide, CCK8, or a 
neutral peptide, leucine enkephalin, were bound to a con- 
siderably less extent. The binding of 'z51-[Tyr'']SRIF to 
the capillaries was nonsaturable up to a concentration of 
1 p.g/ml of unlabeled peptide, and the binding reaction 
was extremely rapid, reaching equilibrium within 5 s at 
either 0°C or  37°C. Approximately 20% of the SRIF 
bound by the microvessels was resistant to acid wash and 
presumably represented internalized peptide. In addition, 
the '251-[Tyr'I]SRIF bound rapidly to the endothelial cy- 
toskeleton remaining after a 1% Triton X-100 extraction 
of the microvessels. The peptide-cytoskeletal binding 
reaction was nonsaturable up to 1 pg/ml of unlabeled 
[Tyr'lISRIF, but it was inhibited by 0.5% polylysine or 
0.8 M KCI and was stimulated by 1 mM dithiothreiotol. 
These studies suggest that brain microvessels rapidly se- 
quester and degrade SRIF analogues and that this may 
represent one mechanism for rapid inactivation of the 
neuropeptides subsequent to neurosecretion. Key Words: 
Aminopeptidase-Cytoskeleton-Peptides. Pardridge 
W. M. et al. Rapid sequestration and degradation of so- 
matostatin analogues by isolated brain microvessels. J .  
Neurochem. 44, 1178- I184 (1985). 
Brain capillaries make up the blood-brain barrier 
(BBB) in vivo. Previous studies of peptide interac- 
tions with brain capillaries have focused on circu- 
lating peptides such as insulin, and receptors for 
insulin have been shown to exist on the luminal 
aspect of the brain capillary (Pardridge, 1983). In 
addition to circulating peptides, it is likely that brain 
capillaries interact with brain-derived peptides 
which may function as neurotransmitters (Krieger 
and Martin, 1981) or neuromodulators of cerebral 
blood flow (Lindvall and Owman, 1981; Hanko et 
al., 1982). For example, vasoactive intestinal pep- 
tide (VIP), neurotensin, substance P, and bombesin 
have all been localized in brain vessel walls 
(Uddman et al., 1981, 1983; Hanko et al., 1982). In 
the cat, VIP produces dilatation and somatostatin 
(SRIF) causes vasoconstriction of the pial artery 
(Hanko et al., 1982). It is possible that neuropep- 
tides such as VIP or SRIF regulate blood flow by 
interacting with arteriolar smooth muscle cells. In 
addition, neuropeptides may interact with capillary 
endothelial cells to modulate endothelial perme- 
ability to circulating water, nutrients, or plasma 
proteins in parallel to peptide alterations in cerebral 
blood flow (Heistad et al., 1981). Moreover, the site 
of neuropeptide enzymatic inactivation in brain re- 
mains unknown and may be localized in brain cap- 
illary endothelia. For example, previous studies 
have shown that a tyrosine-directed aminopepti- 
dase (Pardridge and Mietus, 1981) and a dipeptidyl 
dipeptidase activity (Brecher et al., 1978) are 
present in brain capillaries. Therefore, the present 
studies were designed to assess brain capillary 
binding and metabolism of a model neuropeptide, 
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SRIF, using two different ana logues ,  [Tyr'ISRIF 
and  [Tyr"]SRIF. 
MATERIALS AND METHODS 
Isolation of brain microvessels 
Microvessels were isolated from the brains of mature 
steers using modifications of the mechanical homogeni- 
zation technique of Goldstein et al. (1975). This prepa- 
ration consists primarily of capillaries, but also contains 
minor amounts of small arterioles as well as erythrocytes 
trapped in the microvessel lumen. Steer brains were ob- 
tained on the morning of isolation from a local slaughter- 
house and transported to the lab in ice-cold buffer B (103 
mMNaC1,4.7 mM KCI, 2.5 mMCaCI,, 1.2 mM KH,PO,, 
1.2 mM MgSO,, 15 mM N-2-hydroxyethylpiperazine-N'- 
2-ethanesulfonic acid (HEPES), pH 7.4). Approximately 
80 g of cortex was scraped off two brains after the re- 
moval of the pial membrane. Brain tissue was homoge- 
nized in a fivefold volume excess of buffer A with a hand- 
held Teflon homogenizer with a 0.25-mm clearance using 
13 up-and-down strokes. Buffer A consisted of buffer B 
plus 25 mM NaHCO,, 10 mM glucose, 1 mM sodium 
pyruvate, and 1 gil00 ml bovine albumin. The homoge- 
nate was suspended in an equal volume of 26% dextran 
(MW = 79,500) to yield a final 13% dextran, and was 
centrifuged for 10 min at 5,800 g at 4°C. The pellet was 
pooled in 20 ml of buffer A and passed over a 210 pm 
nylon mesh (Tetko, Elmsford, NY). The arterioles were 
left on top of the mesh and the capillaries, red cells, and 
nuclei were collected as the filtrate through the mesh. 
This mixture was passed over a 3 x 4-cm glass bead 
column (0.45-mm glass beads) and the column was 
washed with 400 ml of buffer A. The glass beads with the 
adherent microvessels were transferred to a beaker and 
swirled, and the beads were allowed to settle. The su- 
pernatant containing the microvessels was decanted and 
spun at 500 g for 5 min at 4°C and resuspended in buffer 
A minus CaC1, for cryopreservation at -70°C in 10% 
dimethyl sulfoxide (DMSO) and 0.5 gil00 ml bovine al- 
bumin. The capillaries were recovered from the cryo- 
preservation with a 50% yield. No changes in SRIF se- 
questration by microvessels were observed in the cryo- 
preserved capillaries as compared with the freshly 
isolated capillaries. 
Bovine brain capillary endothelial cells were also pre- 
pared by the method of Bowman et al. (1983). Cortex was 
obtained from two bovine brains and placed in approxi- 
mately 250 ml of Dulbecco's modified Eagle medium 
(DMEM); then the tissue was minced with a razor blade 
on a petri dish. This solution was brought to 500 ml with 
DMEM and dispase was added to a final concentration 
of 0.5%. The solution was then placed at 37°C and was 
stirred for approximately 2 h. The homogenate was cen- 
trifuged at 1,000 g at 4°C for 10 min and the pellet was 
resuspended in 250 ml of DMEM containing 13% dextran. 
This suspension was then centrifuged at 5,800 g for 10 
min at 4°C. The pellets were pooled in 20 ml of DMEM 
and passed over a 210 pm nylon mesh as described 
above. At this stage, more than 95% of the microvessels 
obtained with the enzymatic homogenization technique 
excluded trypan blue. We found that passage of these 
microvessels over a glass bead column substantially in- 
creased the fraction of trypan blue-positive microvessels. 
Consequently, the glass bead column step was omitted 
and the microvessels were separated from the red blood 
cells with two sequential Percoll density gradient centrif- 
ugations. The microvessels and red cells that passed 
through the 210 pm nylon mesh were concentrated by 
centrifugation at 1,000 g for 5 min at 4°C. The pellet was 
resuspended in a small volume of DMEM and was lay- 
ered on top of a pre-established 50% Percoll gradient in 
medium 199 and 30 mM Na HEPES (pH 7.4) and centri- 
fuged at 1,000 g at 4°C for 10 min. The Percoll gradient 
resulted in the formation of three layers: a top layer of 
cellular debris, a middle layer of microvessels, and a 
bottom layer of red cells. The middle microvessel layer 
was collected and washed free of Percoll with DMEM. 
Since this layer was still contaminated with red cells after 
or e Percoll gradient, the microvessel layer was applied 
to a second pre-established 50% Percoll gradient and cen- 
trifuged as described above. Complete elimination of the 
red cells from the microvessel preparation was not pos- 
sible since the microvessels isolated with an enzymatic 
homogenization technique contained numerous red cells 
within the lumen of the capillary. The Percoll gradient 
was pre-established by centrifugation of the Percoll-me- 
dium 199 mixture in a fixed-angle rotor at 27,000 g for 50 
min at 4°C. The final microvessels prepared with the en- 
zymatic homogenization technique were more than 90% 
trypan blue negative. Conversely, the capillaries obtained 
with the mechanical homogenization were approximately 
90% trypan blue positive. 
Incubation conditions 
Approximately 150 kg of protein from microvessels 
was mixed with various concentrations of "'I-~Iyrl]SRIF 
or 1251-[Tyr11]SRIF and [3H]inulin (used as an extravas- 
cular space marker) in 450 pl of Ringer-HEPES buffer 
(RHB: 141 mM NaCl, 4 mM KCI, 2.8 mM CaCI2, 10 mM 
HEPES, pH 7.4) containing 0. I gil00 ml bovine albumin. 
The ratio of "'II'H was maintained at 0.1. The microves- 
sels and isotopes were incubated at either 4"C, 23"C, or 
37°C for various times. At the end of the incubation, 400 
bl of this mixture was rapidly centrifuged at 10,000 g in 
a microfuge for 45 s; the supernatant was aspirated and 
the tip of the tube was cut with a razor blade into 0.5 ml 
1 M NaOH and counted for 1251. This mixture was then 
heated at 60°C for 30 min to solubilize the protein, and 
microvessel protein was measured with the method of 
Lowry et al. (1951). Another aliquot of the NaOH extract 
was removed for liquid scintillation counting of the 'H 
radioactivity in the presence of lZsI as described previ- 
ously (Pardridge, 1979). The percent bound 12'1 and 3H 
radioactivity per milligram of microvessel protein was 
computed. The ['Hlinulin uptake, which ranged from 1- 
3% mg protein, was subtracted from each I2'I-SRIF up- 
take per milligram of protein to account for isotope 
trapped in the extracellular space of the microvessel 
pellet. 
The internalization of 1251-SRIF was assessed with an 
acid-wash technique which has been used successfully to 
measure the internalization of 1251-insulin by fat cells 
(Olefsky and Kao, 1982) and by brain microvessels (Par- 
dridge et al., 1985). After incubating the capillaries at 
various times with 1251-[Tyr'1]SRIF, 400 pl of the micro- 
vessel solution was transferred to 1.5-rnl Beckman mi- 
crofuge tubes and centrifuged at 10,000 g for 45 s. The 
supernatant was aspirated and the microvessel pellet was 
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resuspended in 450 pI of cold acid wash buffer (0.028 M 
sodium acetate, 0.12 M NaC1, 0.02 M sodium barbital, 
pH 3.0) and was placed on ice for 6 min. Then 400 pl of 
the mixture was transferred to  small Beckman microfuge 
tubes and was centrifuged at 10,000 g for 45 s. The su- 
pernatant was aspirated, the tubes were drained, and the 
pellets were cut into 0.5 ml 1 M NaOH and were analyzed 
as described above. Data are presented as means of du- 
plicates or  triplicates that varied less than 20% from the 
mean. 
Microvessel cytoskeletons were prepared by sus- 
pending microvessel pellets in Triton extraction buffer 
(0.05 M HEPES,  0.15 M NaCI, 1 m M  EGTA, 1% Triton 
X-100, pH 7.4) at 23°C for 10 rnin. The solution was then 
centrifuged at 10,000 g for 10 min at  23°C. The superna- 
tant was aspirated and the microvessel cytoskeletal pellet 
was suspended in 4 ml of wash buffer (0.05 HEPES,  0. I5 
M NaCI, I mM EGTA, p H  7.4) and centrifuged at 10,000 
g for 5 min at 23°C. The supernatant was discarded and 
the microvessel cytoskeleton was washed one more time 
with wash buffer followed by centrifugation. The final 
cytoskeletal pellet was resuspended in 1.5 ml of wash 
buffer and was added to individual tubes containing wash 
buffer, '251-[Tyr'1]SRIF, [3H]inulin, and various concen- 
trations of additives (see Results) in a final volume of 
450 pl. 
High-performance liquid chromatography 
Degradation studies were performed the day of the cap- 
illary isolation. Approximately 10 mgiprotein of micro- 
vessels were suspended in RHB containing 0.3 pCi/ml 
"'I-[Tyr"]SRIF or  "'I-[Tyrl]SRIF at  23°C for up to 20 
min of incubation. At various times of incubation, 0.4 ml 
of microvessels were removed from the incubation and 
rapidly centrifuged at 10,000 g for 30 s a t  4°C. The me- 
dium was aspirated and 0.2 ml of the medium was mixed 
with equal volumes of 2 M acetic acid and stored at  4°C. 
The microfuge tip containing the microvessel pellet was 
cut from the tube and placed in 1 ml of acid ethanol (75% 
ethanol; 15% 1 M HCI) and was placed at 4°C overnight. 
The following day, the cell extract was vortexed and then 
centrifuged at 1,000 g at 4°C for 15 min. A 0.7-ml aliquot 
was removed for HPLC analysis of the acid extract. Re- 
covery of SRIF standards from the acid ethanol extrac- 
tion was 72 2 6% (mean * SE). 
H P L C  r u n s  w e r e  per formed o n  a p B o n d a p a k  C, ,  
column (0.39 x 30 cm, Waters Assoc. ,  Milford, MA) 
using an Altex Scientific model 3 12 MP chromatography 
system. The  buffers used for elution were 2% trifluo- 
roacetic acid (TFA) (buffer A) and 50% acetonitrile in 2% 
TFA (buffer B). The column was eluted at a flow rate of 
1 mlimin at room temperature using the following pro- 
tocol: 5 min at 0% B,  17.5 min gradient of 0-70% B, 10 
min at  70% B, and 5 min gradient a t  70-0% B. Eluted 
fractions were collected and counted for 1251. 
Miscellaneous methods 
[TyrlISRIF, [Tyr"]SRIF, CCKS, and [Tyr8]bradykinin 
were iodinated with chloramine T and [1251]iodine as  de- 
scribed previously (Yamada et al., 1980). Proteins were 
determined with the method of Lowry e t  al. (1951). 
Materials 
['2SI]Iodine was obtained from New England Nuclear 
Corp. (Boston, MA). [Tyr'ISRIF, [Tyrx]bradykinin, and 
h 
5 min - JL 
10 min - A 
I - T Y R  ,-SRIF 
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FIG. 1. HPLC profile of me- 
dium at various times of in- 
cubation of the bovine brain 
microvessels  w i t h  lZ5l- 
[Tyr'ISRIF at 23°C. The mi- 
gration of iodotyrosine (I-ty- 
rosine) and iodo-[Tyr'ISRIF 
internal standards is de- 
noted by the arrows. The lZ5l- 
[Tyr'ISRIF was rapidly con- 
verted to  free '251-tyrosine 
with a half-time of approxi- 
mately 3 min at 23°C. The 
amount of microvessels in 
each incubation was ap- 
proximately 0.8 mg micro- 
vessel protein per 0.5 ml of 
incubation medium. 
CCKS were obtained from Peninsula Labs (Belmont, 
CA). [Tyr'IlSRIF was obtained from Bachem Labs (Tor- 
rance, CA). lodotyrosine, polylysine-4000, and dextran 
(MW = 79,500) were obtained from Sigma Chemical Co. 
(St. Louis ,  MO). Dispase (neutral protease) was pur- 
chased from Boehringer-Mannheim (Indianapolis, IN). 
Bovine albumin (pentex fraction V) was purchased from 
Miles Labs (Elkhart, IN). 
RESULTS 
Capillary degradation of [Tyr'ISRIF 
Initial studies were performed with [Tyr'lSRIF. 
Prior to binding studies with this analogue, degra- 
dation studies were carried out. Aminopeptidase 
degradation of the peptide could result in the for- 
mation of free iodotyrosine and artifactual labeling 
of the microvessels as described previously with 
leucine enkephalin labeled at the N-terminal tyro- 
sine (Pardridge and Mietus, 1981). As shown in Fig. 
1, the incubation analyzed by HPLC showed a pro- 
gressive increase in medium radioactivity comi- 
grating with an iodotyrosine internal standard. The 
t,,* of [Tyr'ISRIF degradation by the microvessels 
was approximately 3 min at room temperature. The 
saturability of [Tyr'ISRIF by capillary aminopepti- 
dase is shown in Fig. 2. In these studies, approxi- 
mately 5 mg protein of brain microvessels were in- 
cubated in 5 ml of RHB at 23°C for 2 min in the 
presence of 0.01 - 100 p M  [Tyr'ISRIF. At the end of 
the incubation, the microvessels were rapidly cen- 
trifuged in a microfuge for 60 s, and acetic acid was 
added to the supernatant to achieve a concentration 
of 0.5 M .  The acid medium extract was placed over- 
night at 4°C and the percent free iodotyrosine in the 
incubation mixture was assessed by HPLC using 
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FIG. 2. The incubation shown in Fig. 1 was repeated at 2 rnin 
at 23°C with various concentrations (0.01-100 pM) of unla- 
beled Tyr-1-SRIF and 0.5 pCi/ml 1z51-[Tyr1]SRIF. The medium 
was processed and  analyzed by HPLC (Materials and 
Methods) and the percent of iz51-tyrosine in the medium was 
determined (upper left) and the rate of aminopeptidase ac- 
tivity was calculated (lower left). An Eadie-Hofstee plot (right) 
of the saturation data provides estimates of the aminopep- 
tidase K, and V,,, for [Tyr'ISRIF. 
the conditions shown in Fig. 1 .  The rate of micro- 
vessel aminopeptidase degradation of [Tyr'ISRIF 
was calculated from the medium percent iodotyro- 
sine and the SRIF concentration. An Eadie-Hofstee 
plot shows that the capillary aminopeptidase deg- 
radation of [TyrIISRIF is characterized by a rela- 
tively low affinity (high K,) and high capacity (high 
Binding studies using '251-[Tyr11]SRIF 
Microvessels were incubated with 1251-[Tyr11]- 
SRIF for periods ranging from 5 s to 30 min at 23°C. 
The uptake during this time period was constant 
(data not shown) and was proportional to the 
amount of microvessel protein (Table I ) .  HPLC 
analysis (not shown) of the medium extract at 30 
rnin of incubation at 23°C showed that more than 
75% of the medium radioactivity coeluted with a 
'251-[Tyr11]SRIF standard. The uptake or binding of 
[Tyr"]SRIF at any time up to 30 min of incubation 
V m a J  * 
TABLE 1. Efiect of microvessel concentration on 
binding O ~ ~ ~ . ~ I - [ T ~ ~ ~ ~ ] S R I F  
p.8, Percent bound 
56 ? 13 1.6 i 0.6 
158 t I 5.8 i 1.2 
402 2 3 12.0 i 3.3 
Data are mean 5 SE (n = 3). The uptake of ['Hlinulin, an 
extracellular space marker, was measured simultaneously and 
was subtracted from the measured uptake of '2SI-[Tyr"]SRIF. 
The microvessels were incubated with the isotopes at 23°C for 
10 min. 
SRlF 
Incubation, 20 min 
23' C 
FIG. 3. The brain uptake of four different peptides by bovine 
brain capillaries during a 20-min incubation at 23°C is shown 
for i251-[Tyr1i ]SR I F, 1z51-[Tyr8] brady ki n i n, lz5I-CCK8, and 
[3H]leucine enkephalin. [The [3H]leucine enkephalin is from 
Pardridge and 'Mietus (1981).] The uptake of (3H]inulin, an 
extracellular space marker, was measured simultaneously 
and was subtracted from the total uptake for each of the lZ5l- 
peptides. 
at room temperature was not saturated by the ad- 
dition of unlabeled [Tyr"]SRIF to the  medium at 
concentrations as high as 1 kg/ml (data not shown). 
The  high degree of nonspecific binding of 
[Tyr"]SRIF was not seen with another basic pep- 
tide, such as  [Tyr8]bradykinin, with an acidic pep- 
tide, such as CCK8, or with a neutral peptide, such 
as leucine enkephalin (Fig. 3). In addition, the non- 
specific binding of [Tyr"]SRIF to the microvessels 
was independent of incubation temperature (Fig. 4). 
About 15-20% of the [Tyr"lSRIF sequestered by 
the microvessels was resistant to a mild acid wash 
(Fig. 4) indicating the majority of the peptide was 
bound to the exterior cell surface. Also, the late 
addition of various dilutions of an antisera directed 
against [Tyr'l]SRIF to  the incubation media re- 
sulted in a progressive decrease in the amount of 
peptide sequestered by the microvessel (Table 2). 
The amount of [Tyrl'ISRIF bound to the micro- 
vessel was constant for up to 30 min at 4°C (Fig. 4) 
.I I i I 
0 10 20 30 0 10 20 30 
MINUTES 
FIG. 4. The percent of 1z51-[Tyr11]SRIF bound to brain capil- 
laries at 37°C or 4°C is shown versus incubation time. The 
earliest time point in  all curves is 5 s of incubation. The acid- 
resistant portion of the total binding was determined by a 
mild acid wash of the microvessels at 4°C subsequent to 
incubation (Materials and Methods). The decay in  micro- 
vessel-bound SRlF at 37°C presumably represents endopep- 
tidase degradation of the SRlF analogue (see Fig. 5) and 
release of the radiolabeled SRlF metabolite. The uptake of 
[3H]inulin, an extracellular space marker, was measured si- 
multaneously and was subtracted from the total uptake for 
each of the lZ51-peptides. 
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or at 23°C (data not shown). However, at 37"C, the 
amount of 12SI-[Tyr'1]SRIF associated with the mi- 
crovessel decreased rapidly with incubation time. 
The release of the peptide from the microvessel at 
physiologic temperatures is likely due to endopep- 
tidase degradation of the peptide by the micro- 
vessel. As shown in Fig, 5 ,  HPLC analysis of the 
cell extract of the microvessel after 0-, I - ,  5 - ,  or 20- 
rnin incubations with i2SI-[Tyr"]SRIF at 23°C re- 
sulted in the formation of multiple minor radioactive 
peaks with a prominent peak that comigrated with 
the iodotyrosine internal standard. HPLC profiles 
of the cell extract after incubation at 37°C were not 
performed. 
Binding of [Tyr"]SRIF to 
microvessel cytoskeleton 
To test whether the [TyrIlISRIF sequestration to 
the microvessel involved binding of the peptide to 
the microvessel cytoskeleton, the studies shown in 
Fig. 6 were performed. Microvessels were incu- 
bated in buffer containing 1% Triton X-100 at room 
temperature for 10 rnin and the microvessel pellet 
formed after centrifugation was used as the cyto- 
skeleton (Materials and Methods). Binding of the 
TABLE 2. Effects of anti-[Tyr"]SRIF sheep antiserum 
on the microvessel uptuke of '251-[Tyri1]SRIF 
Antisera dilution Percent bound/mg, 
control 
I :so ,000 
1 : 10,000 
1:5,000 
I : 1,000 
1 : l O O  
1 ? . 1  ? 0.9 
10.9 ? 1.4 
7.5 5 0.1 
5.7 ? 0.2 
2.9 ? 2.0 
0 
Data are mean t SE (n = 3). The capillaries were incubated 
for 15 min with '251-[Tyr'i]SRlF and [3H]inulin followed by the 
addition of the antiserum dilution and incubation for an addi- 
tional 15 min. 
' 2 5 ~ - ~ ~ ~ , , - ~ ~ ~ ~  - 0 ImM DTT 1.5 











FIG. 6. The percent binding of 1251-[Tyr11]SRIF to Triton X- 
100-resistant microvessel cytoskeleton at room temperature 
for a 10-min incubation is shown for a control and various 
experimental incubations. The open bars represent the per- 
cent binding of the SRlF and the closed bars represent the 
retention of [3H]inul in, an extravascular space marker. 
Polylysine and high concentrations of KCI inhibited the SRlF 
sequestration by the microvessel cytoskeleton and dithio- 
threitol enhanced the binding of the peptide to the cytoskel- 
eton. However, none of these reagents altered the retention 
of the [3H]inulin extracellular space marker. 
12sI-[Tyr1 'ISRIF to the microvessel cytoskeleton 
was rapid and reached an equilibrium point by 5 s 
at room temperature (data not shown). In addition, 
the amount of [Tyrl'ISRIF bound by the cytoskel- 
eton was manyfold greater than the amount of 
[3H]inulin associated with the cytoskeleton (Fig. 6). 
Sequestration of the peptide by the cytoskeleton 
was not inhibited by high concentrations of unla- 
beled SRIF, by acid or alkaline pH, but was inhib- 
ited by high concentrations of potassium chloride 
or another cation, polylysine, and was stimulated 
by 1 mM dithiothreitol (Fig. 6). 
Uptake of [Tyr"]SRIF by enzymatically 
prepared microvessels 
Bovine brain microvessels were prepared by a 
0.5% dispase enzymatic homogenization technique 
(Materials and Methods), and sequestration of 1251- 
[Tyr"]SRIF by the dispase microvessels was 
studied. As shown in Table 3, the uptake of the 
TABLE 3. Uptake of "51-1Tyr1i]SRIF by  bruin 
cupilluries iJolated with an enzymatic 
homogenization technique 
Time Percent boundimg, 
10.5 2 0.2 5 s  
0.5 rnin 10.4 ? 0.4 
10.5 t 0.1 1 min 
14.9 2 0.2 10 min 
30 min 12.8 t 0.1 
Data are mean ? SE (n = 3 ) .  The uptake of ('Hlinulin. an 
extracellular space marker, was measured simultaneously and 
was subtracted from the measured uptake of '251-[Tyri']SRlF. 
The concentration of capillaries was 0.22 mg, per 0.45 ml incu- 
bation volume and the incubation temperature wab 23°C. 
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peptide by the dispase capillaries reached equilib- 
rium by 5 s of incubation at 23°C and was compa- 
rable in magnitude to that observed with the micro- 
vessels obtained by a mechanical homogenization 
technique, e.g., Table 2. The sequestration of 
[Tyr"]SRIF by the dispase microvessels was non- 
saturable up to SRIF concentrations of 1 pgiml 
(data not shown). 
DISCUSSION 
The present studies have led to two major find- 
ings. First, SRIF analogues such as [Tyr"]SRIF are 
rapidly and nonspecifically bound to the exterior of 
brain microvessels and also to the microvessel cy- 
toskeleton. Second, [Tyr'ISRIF is rapidly metabo- 
lized by capillary aminopeptidase and [Tyrl'ISRIF 
is metabolized more slowly, presumably by a mi- 
crovessel endopeptidase. Thus, the microvessel 
degradation of SRIF analogues is similar to the me- 
tabolism of SRIF in other tissues such as liver, 
where the clearance of [Tyr'ISRIF by liver is sixfold 
faster than the clearance of [Tyr"]SRIF (Sacks et 
al., 1984). In addition, Patel and Wheatley (1983) 
have shown that the major pathway of SRIF-14 deg- 
radation in vivo is via aminopeptidase. The rapid 
metabolism of SRIF-14 in vivo, tli2 = 0.5-1.3 min 
(Seal et at., 1982; Patel and Wheatley, 1983), is con- 
sistent with a major endothelial origin of the in vivo 
aminopeptidase activity. 
The rapid nonspecific binding of [Tyr' 'ISRIF pre- 
vents the detection of any saturable SRIF receptors 
on the microvessel surface membrane, similar to the 
SRIF receptors identified on brain cell membranes 
(Srikant and Patel, 1981; Epelbaum et al., 1982; 
Reubi et al., 1982). Major concerns in this regard 
are (1) the parallel behavior of native SRIF and io- 
dinated SRIF analogues, and (2) the possibility that 
the nonspecific binding of [Tyr"]SRIF to the brain 
microvessel is an artifact caused by cell isolation or 
peptide iodination procedures. In regard to the pos- 
sible physiologic significance of SRIF sequestration 
by brain capillaries, the following considerations 
are relevant. First, the high degree of nonspecific 
binding of [Tyr'IISRIF to the microvessel is not 
seen for all peptides. Acidic peptides, such as 
CCK8, or neutral peptides, such as leucine enkeph- 
alin, are bound very little, if at all, by the micro- 
vessels (Fig. 3). Moreover, another basic peptide, 
[T~r~lbradykinin,  is bound only minimally com- 
pared with [Tyrll]SRIF (Fig. 3). Second, the uptake 
of [Tyr'IlSRIF is not an artifact caused by isolation 
of microvessels with mechanical homogenization. 
Brain microvessels obtained with this technique are 
damaged by the shear force generated in even the 
gentlest mechanical homogenization and the capil- 
laries do not exclude trypan blue (Pardridge and 
Mietus, 1981). However, brain microvessels can 
also be obtained by an enzymatic technique and 
these capillaries do exclude trypan blue (Bowman 
et al., 1983). We observed that microvessels ob- 
tained with this latter technique rapidly and actively 
sequester [Tyr"]SRIF (Table 3). 
The sequestration of neuropeptides such as SRIF 
by brain microvessels could serve as a mechanism 
for rapid clearance of these neuropeptides from the 
brain interstitial space subsequent to neurosecre- 
tion. Indeed, the mechanism of inactivation of pep- 
tides by brain is at present unclear since presyn- 
aptic reuptake or postsynaptic degradation of pep- 
tides has not been documented, similar to what 
occurs for the amine neurotransmitters (Schwartz 
et al., 1981). Rapid binding of neuropeptides to 
brain microvessels could also anchor the peptide 
and make the compound accessible to capillary pep- 
tidases. For example, the rapid debinding of 
[Tyr"]SRIF from the microvessels at 37°C (Fig. 4) 
suggests that significant endopeptidase activity oc- 
curs at physiologic temperatures. 
Finally, the interaction of [Tyr"]SRIF with the 
Triton-resistant microvessel cytoskeleton is of in- 
terest since recent studies suggest that other neu- 
ropeptides, such as nerve growth factor, interact 
with the cellular cytoskeleton (Calissano and She- 
lanski, 1980). The data in Fig. 6 suggest that the 
SRIFicytoskeleton interaction is resistant to acid or 
alkaline pH but is sensitive to cationic agents such 
as polylysine or potassium and is augmented by 
sulfhydryl reagents such as dithiothreitol. Since 
peptide interactions with the microvessel cytoskel- 
eton might lead to changes in BBB permeability, the 
neuropeptide-microvessel cytoskeleton interactions 
may prove to be of physiologic significance. 
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